A detailed history of Axs Investments LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Axs Investments LLC holds 9,090 shares of JNJ stock, worth $1.51 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
9,090
Previous 7,650 18.82%
Holding current value
$1.51 Million
Previous $1.21 Million 9.75%
% of portfolio
0.38%
Previous 0.44%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $207,907 - $227,203
1,440 Added 18.82%
9,090 $1.33 Million
Q1 2024

Aug 16, 2024

SELL
$155.22 - $162.74 $62,398 - $65,421
-402 Reduced 4.42%
8,688 $1.37 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $227,086 - $238,088
-1,463 Reduced 16.05%
7,650 $1.21 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $36,545 - $39,878
251 Added 2.83%
9,113 $1.43 Million
Q3 2023

Nov 09, 2023

SELL
$155.75 - $174.48 $48,749 - $54,612
-313 Reduced 3.41%
8,862 $1.38 Million
Q2 2023

Aug 10, 2023

SELL
$154.35 - $166.11 $30,870 - $33,222
-200 Reduced 2.13%
9,175 $1.52 Million
Q1 2023

May 12, 2023

BUY
$151.05 - $180.26 $201,500 - $240,466
1,334 Added 16.59%
9,375 $1.45 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $26,272 - $29,485
-164 Reduced 2.0%
8,041 $1.42 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $777,374 - $859,738
4,622 Added 129.0%
8,205 $1.46 Million
Q1 2022

May 13, 2022

SELL
$158.14 - $179.59 $651,853 - $740,269
-4,122 Reduced 53.5%
3,583 $635,000
Q4 2021

Feb 09, 2022

BUY
$155.93 - $173.01 $917,024 - $1.02 Million
5,881 Added 322.42%
7,705 $1.32 Million
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $820,420 - $911,707
-5,080 Reduced 73.58%
1,824 $295,000
Q2 2021

Jul 28, 2021

BUY
$159.48 - $171.07 $266,491 - $285,857
1,671 Added 31.93%
6,904 $1.14 Million
Q1 2021

May 10, 2021

BUY
$153.07 - $170.48 $801,015 - $892,121
5,233 New
5,233 $860,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Axs Investments LLC Portfolio

Follow Axs Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axs Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axs Investments LLC with notifications on news.